RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
Cited by 148
Related Papers
Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression
|Science Advances|2023|173
Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
|Cell Reports Medicine|2023|167
RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss
|EMBO Reports|2021|140